2-naphthylamine has been researched along with HIV in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Blackard, JT; Celentano, DD; Jamieson, DJ; King, CC; Klein, RS; Kong, L; Lin, D; Mayer, KH; Ngwaga, T; Schoborg, C; Sobel, JD; Tavis, JE; Taylor, LE | 1 |
Fan, H; Fu, Z; Huang, P; Tian, T; Wang, Y; Wu, J; Xia, X; Ye, X; Yue, M; Zhang, Y | 1 |
2 other study(ies) available for 2-naphthylamine and HIV
Article | Year |
---|---|
Diversity of the hepatitis C virus NS5B gene during HIV co-infection.
Topics: 2-Naphthylamine; Adult; AIDS-Related Opportunistic Infections; Amino Acid Sequence; Antiviral Agents; CD4 Lymphocyte Count; Cohort Studies; Coinfection; Drug Resistance, Viral; Female; Genetic Variation; Genotype; Hepacivirus; Hepatitis C; HIV; Humans; Phylogeny; RNA-Dependent RNA Polymerase; RNA, Viral; Sofosbuvir; Sulfonamides; Uracil; Viral Nonstructural Proteins | 2020 |
Effectiveness of ombitasvir/paritaprevir/ritonavir, dasabuvir for HCV in HIV/HCV coinfected subjects: a comprehensive analysis.
Topics: 2-Naphthylamine; Adult; Anilides; Antiviral Agents; Carbamates; Clinical Trials as Topic; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; HIV; HIV Infections; Humans; Lactams, Macrocyclic; Macrocyclic Compounds; Male; Middle Aged; Observational Studies as Topic; Proline; Ritonavir; Sulfonamides; Sustained Virologic Response; Uracil; Valine | 2019 |